A Health Podyssey

Protecting Public Health in a Politicized Era w/ Michael Osterholm

Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing]. Health Affairs' Rob Lott interviews Michael T. Osterholm, the director of the Center for Infectious Disease Research and Policy (CIDRAP), about the future of U.S. public health, the politicization of vaccine oversight, and why fragmented state guidance threatens pandemic preparedness. He also discusses his new book, The Big One: How We Must Prepare for Future Deadly Pandemics [https://chevaliersbooks.com/book/9780316258340]. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support [https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider], we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing].

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing]. In this episode, Rob Lott interviews Jennifer Kao of the UCLA Anderson School of Management in front of a live audience about her paper in the October 2025 issue of Health Affairs exploring the impact of risk evaluation and mitigation strategies [https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2024.01476?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=october+2025+issue] on generic approvals of US pharmaceutical products. Order the October 2025 issue of Health Affairs [https://www.pubservice.com/backissue/subbi.aspx?CO=PJ&PC=HR&BI=HRI&utm_medium=podcast&utm_source=A+health+podyssey]. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support [https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider], we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing].

The Different Costs — and Sites — of Care for Commercial Insurers w/ Matthew Maughan

Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing]. Health Affairs' Rob Lott interviews Matthew Maughan of Brown University about his paper exploring how commercial insurers paid more for procedures [https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00297?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=october+2025+issue] at hospital outpatient departments as compared to ambulatory surgical centers. Order the October 2025 issue of Health Affairs [https://www.pubservice.com/backissue/subbi.aspx?CO=PJ&PC=HR&BI=HRI&utm_medium=podcast&utm_source=A+health+podyssey]. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support [https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider], we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing].

Profits vs. Patient Care: Alexander Soltoff on Private Equity in Hospice Care

Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing]. Health Affairs' Rob Lott interviews Alexander Soltoff of Emory University about his recent paper exploring how private equity-owned hospices reported higher profits and lower patient care spending [http://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00327?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=october+2025+issue] when compared to other ownership models. Order the October 2025 issue of Health Affairs [https://www.pubservice.com/backissue/subbi.aspx?CO=PJ&PC=HR&BI=HRI&utm_medium=podcast&utm_source=A+health+podyssey]. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support [https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider], we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing].

Can Challenge Prizes Transform Drug Discovery? w/ Tris Dyson

Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing]. Health Affairs' Rob Lott interviews Tris Dyson, Founder of Challenge Works [https://challengeworks.org/] on his efforts in cultivating challenge prizes as an opportunity to nurture innovation in science and health care, the newly launched Longitude Prize on ALS, the transformation of drug discovery, and more. Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support [https://www.healthaffairs.org/membership?utm_medium=podcast&utm_source=a+health+podyssey&utm_campaign=insider], we can continue to keep our digital publication Forefront and podcast Subscribe to UnitedHealthcare's Community & State newsletter [https://www.uhccommunityandstate.com/forms/newsletterregistrationform?cid=CS_B2B|Affiliate_Marketing].